History of meningococcal vaccines and their serological correlates of protection

被引：52
作者：
Vipond, Caroline [1 ]
Care, Rory [1 ]
Feavers, Ian M. [1 ]
机构：
[1] NIBSC, Div Bacteriol, Potters Bar EN6 3QG, Herts, England
来源：
VACCINE | 2012年 / 30卷
关键词：
Vaccine; Meningitis; Polysaccharide; Outer membrane vesicle; Serological correlate; Complement; Bactericidal antibody; Gene expression; OUTER-MEMBRANE PROTEIN; C CONJUGATE VACCINE; MENINGITIDIS GROUP-B; FACTOR-H BINDING; NEISSERIA-MENINGITIDIS; SEROGROUP-C; GROUP-A; IMMUNE-RESPONSE; VESICLE VACCINE; POLYSACCHARIDE VACCINE;
D O I：
10.1016/j.vaccine.2011.12.060
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
For over a hundred years Neisseria meningitidis has been known to be one of the major causes of bacterial meningitis. However, effective vaccines were not developed until the latter part of the 20th century. The first of these were based on purified high molecular weight capsular polysaccharides and more recently the development of glycoconjugate vaccines has made paediatric immunisation programmes possible. The prevention of group B meningococcal disease has remained a challenge throughout this period. This review charts the history of the development of meningococcal vaccines and the importance of serological correlates of protection in their evaluation. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码：B10 / B17
页数：8
相关论文
共 125 条
  • [21] Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines
    Donnelly, John
    Medini, Duccio
    Boccadifuoco, Giuseppe
    Biolchi, Alessia
    Ward, Joel
    Frasch, Carl
    Moxon, E. Richard
    Stella, Maria
    Comanducci, Maurizio
    Bambini, Stefania
    Muzzi, Alessandro
    Andrews, William
    Chen, Jie
    Santos, George
    Santini, Laura
    Boucher, Philip
    Serruto, Davide
    Pizza, Mariagrazia
    Rappuoli, Rino
    Giuliani, Marzia Monica
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (45) : 19490 - 19495
  • [22] Eskola Juhani, 1993, Current Opinion in Pediatrics, V5, P55, DOI 10.1097/00008480-199302000-00009
  • [23] Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine
    Feiring, Berit
    Fuglesang, Jan
    Oster, Philipp
    Naess, Lisbeth M.
    Helland, Oddveig S.
    Tilman, Sandrine
    Rosenqvist, Einar
    Bergsaker, Marianne A. R.
    Nokleby, Hanne
    Aaberge, Ingeborg S.
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (07) : 790 - 796
  • [24] Immunization of human subjects with the specific carbohydrates of Type III and the related Type VIII pneumococcus
    Finland, M
    Ruegsegger, JM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1935, 14 (06) : 829 - 832
  • [25] Finland M, 1935, J IMMUNOL, V29, P285
  • [26] FINNE J, 1983, LANCET, V2, P355
  • [27] POLYSIALIC ACID - A GLYCOPROTEIN CARBOHYDRATE INVOLVED IN NEURAL ADHESION AND BACTERIAL-MENINGITIS
    FINNE, J
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1985, 10 (03) : 129 - 132
  • [28] Vaccine potential of the Neisseria meningitidis 2086 lipoprotein
    Fletcher, LD
    Bernfield, L
    Barniak, V
    Farley, JE
    Howell, A
    Knauf, M
    Ooi, P
    Smith, RP
    Weise, P
    Wetherell, M
    Xie, XL
    Zagursky, R
    Zhang, Y
    Zlotnick, GW
    [J]. INFECTION AND IMMUNITY, 2004, 72 (04) : 2088 - 2100
  • [29] FRANCIS THOMAS, 1930, JOUR EXP MED, V52, P573, DOI 10.1084/jem.52.4.573
  • [30] PROTECTION AGAINST GROUP-B MENINGOCOCCAL DISEASE .1. COMPARISON OF GROUP-SPECIFIC AND TYPE-SPECIFIC PROTECTION IN CHICK-EMBRYO MODEL
    FRASCH, CE
    PARKES, L
    MCNELIS, RM
    GOTSCHLICH, EC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 144 (02) : 319 - 329
12345678910